Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.

Drugs in R&D
Steven G Chrysant

Abstract

Black hypertensive patients are more resistant to angiotensin-converting enzyme (ACE) inhibitor monotherapy than White patients. This resistance can be overcome with the combination of ACE inhibitors with diuretics or calcium-channel blockers (CCBs). The objective of this clinical investigation was to evaluate the antihypertensive effectiveness of monotherapy with the ACE inhibitor benazepril or the CCB amlodipine and their combination in Black and White hypertensive patients in two separate studies. This was a post hoc analysis of data from two separate studies, pooled because of their similarities, to increase the sample size. Outpatient Black and White hypertensive patients were selected for these studies. In study H2303, 201 patients of both sexes and races, whose mean seated diastolic blood pressure (MSDBP) was ≥95 mmHg after 4 weeks of single-blind treatment with benazepril 40 mg/day, were randomized into two groups. Group 1 received benazepril 40 mg/day and group 2 received amlodipine/benazepril 5/40 mg/day, which was uptitrated to amlodipine/benazepril 10/40 mg/day at week 4 of the study. In study H2304, 812 similar patients, whose MSDBP was ≥95 mmHg after 4 weeks of single-blind treatment with amlodipine 10 mg/day, wer...Continue Reading

References

Aug 17, 1999·Journal of Human Hypertension·D E HillemanR L Wurdeman
Apr 3, 2002·The Journal of Clinical Hypertension·William C CushmanRobert K Zeldin
Jun 21, 2002·American Journal of Hypertension·Franz H MesserliJoel M Neutel
Jan 31, 2003·The Journal of Clinical Hypertension·Elijah Saunders, James R Gavin
Mar 8, 2003·Archives of Internal Medicine·Janice G DouglasUNKNOWN Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Aug 27, 2003·The Journal of Clinical Hypertension·Domenic A Sica
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 6, 2004·American Journal of Hypertension·Steven G Chrysant, George L Bakris
Jul 20, 2006·The Journal of Clinical Hypertension·Steven G Chrysant, Mohammed Ibrahim
Mar 14, 2007·Journal of Hypertension·Willem J W BosGert A van Montfrans
Oct 9, 2008·Clinical Drug Investigation·Steven G Chrysant
Oct 11, 2008·The Journal of Clinical Hypertension·Steven G Chrysant
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
May 27, 2010·JAMA : the Journal of the American Medical Association·Brent M EganR Neal Axon
Oct 6, 2010·Hypertension·John M FlackUNKNOWN International Society on Hypertension in Blacks
Apr 13, 2011·The American Journal of Cardiology·Steven G Chrysant, George S Chrysant

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.